Evidence map›Paper›PMID 32741100›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Cutaneous leukocyte lineages in tolerant large animal and immunosuppressed clinical vascularized composite allograft recipients.

David A Leonard, Harrison R Powell, Matthew W Defazio, Kumaran Shanmugarajah, Melissa Mastroianni, Ivy A Rosales, Evan A Farkash, Robert B Colvin, Mark A Randolph, David H Sachs and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Hand transplantation: can we balance the risks and benefits?The Journal of hand surgery, European volume · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

David A LeonardCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harrison R PowellCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Matthew W DefazioCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kumaran ShanmugarajahCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Melissa MastroianniCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ivy A RosalesDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-0621-3202
Evan A FarkashDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Robert B ColvinDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4493-4150
Mark A RandolphDivision of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-0877-9832
David H SachsCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Josef M KurtzCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Curtis L CetruloCenter for Transplantation Sciences, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard University · USMassachusetts General Hospital · US

Funding

RES FACIL CONST: XENOTRANSPLANTATION, LUNG ALLOGRAFT REJECTION IN SWINEC06RR020135 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SLAVIN, PETER L · 2004 to 2004
$2.7M
NCRR NIH HHS C06 RR020135
6 · The paper itself

Abstract

Vascularized composite allografts (VCAs) can restore fully functional anatomic units in patients with limb amputations or severe facial tissue loss. However, acute rejection of the skin is frequently observed and underscores the importance of developing tolerance induction protocols. In this study, we have characterized the skin immune system in VCAs. We demonstrate infiltration of recipient leukocytes, regardless of rejection status, and in tolerant mixed hematopoietic chimeras, the co-existence of these cells with donor leukocytes in the absence of rejection. Here we characterize the dermal T cell and epidermal Langerhans cell components of the skin immune system in our porcine model of VCA tolerance, and the kinetics of cutaneous chimerism in both of these populations in VCAs transplanted to tolerant and nontolerant recipients, as well as in host skin. Furthermore, in biopsies from the first patient to receive a hand transplant in our program, we demonstrate the presence of recipient T cells in the skin of the transplanted limb in the absence of clinical or histological evidence of rejection.

Indexed as

Composite Tissue AllograftsAnimalsGraft RejectionGraft SurvivalHumansLeukocytesSwineTransplantation Chimeraanimal models: porcinetolerance: mechanismstranslational research/sciencevascularized composite and reconstructive transplantation

Identifiers

PMID32741100
PMCPMC7854956
OpenAlexW3046456992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.